作者: Robert de Wilton Marsh , Marshall S. Baker
DOI: 10.1007/978-3-319-22780-1_5
关键词:
摘要: Pancreatic cancer is the fourth leading cause of death in USA. However, last decade, there has been considerable progress understanding and treatment this disease we are starting to see an impact on survival quality life. Chemotherapeutic surgical options have increased, refinements classification staging reflect both biology these cancers, critical interface between tumors adjacent mesenteric hepatic vasculature, proposed. Modern has, necessity, evolved into a multidisciplinary, multimodality exercise choices regarding type sequencing therapeutic modalities now much more complex. Borderline resectable locally advanced cancers particularly challenging regard as all available will usually be employed at some time during treatment, goals therapy frequently need adjusted. Discussion every patient multidisciplinary conference or clinic become essential establishing appropriate care plans, composition conduct such meetings analyzed defined. Academic productivity also enhanced by approach, educational component valuable for experienced personnel trainees. Future add complexity patients molecular genetic data increasingly detailed, biologics, vaccines, immunotherapies incorporated treatment. Collaboration connectivity providers from disciplines ever providing optimal results.